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Abstrat
As ell proliferation is limited due to the loss of telomere repeats in DNA
of normal somati ells during division, telomere attrition an possibly play
an important role in determining the maximum life span of organisms as well
as ontribute to the proess of biologial ageing. With omputer simulations
of ell ulture development in organisms, whih onsist of tissues of normal
somati ells with nite growth, we otain an inrease of life span and life ex-
petany for longer telomeri DNA in the zygote. By additionally onsidering
a two-mutation model for arinogenesis and indenite proliferation by the
ativation of telomerase, we demonstrate that the risk of dying due to aner
an outweigh the positive eet of longer telomeres on the longevity.
Keywords: Biologi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1 Introdution
Telomeres are tandem repeated nonoding sequenes of nuleotides at both ends of
the DNA in eukaryoti hromosomes stabilizing the hromosome ends and prevent-
ing them from end-to-end fusion or degradation [1℄. Polymerase annot ompletely
repliate the 3' end of linear DNA, so telomeres are shortened at eah DNA replia-
tion [2℄. This end repliation problem leads to a nite repliative apaity for normal
somati ells [3℄. They an only divide up to a ertain threshold, the Hayik limit
[4, 5℄. The enzyme telomerase, repressed in most normal somati ells, synthesizes
and elongates telomere repeat sequenes at the end of DNA strands so that ertain
ells like germline ells are immortal and indenite in growth [6, 7℄.
Most forms of aner follow from the aumulation of somati mutations [8, 9℄.
Caner-derived ell lines and 85-90% of primary human aners are able to synthesize
high levels of telomerase and thus are able to prevent further shortening of their
telomeres and proliferate indenitely [10℄. But if ells are premalignant or already
anerous and telomerase is not yet ativated, the proliferative apaity of these
ells and therefore the aumulation of mutations is determined by the remaining
telomere length [11℄. So the frequeny of malignant aner should be higher for
longer telomeres in normal somati ells.
Reently published data show that longer telomeri DNA inreased the life span
of nematode worms [12℄. Experiments are running [13℄ whether there is a positive
eet on the longevity also for organisms with renewing tissues if the telomere length
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in fetal ells is inreased [13℄. As the probability for the inidene of aner is
orrelated to the repliative potential of the mutated ells [14℄, one an ask the
following question: Is an extension of life span possible if telomeres in embryoni
ells are elongated and aner is onsidered? An answer to this question ould be
given by omputer simulations as the presented model fouses on organismal ageing
due to the loss of telomeres in DNA and neglets other eets whih lead to a
dereasing survival probability with age.
As shortening of telomeres is one of the supposed mehanisms of ageing on ellular
level, most stohastial and analytial studies investigate this relationship [15, 16,
17, 18, 19℄. A theoretial model whih diretly relates telomere attrition to human
ageing was rst suggested by Aviv et al. [20℄. Here we present a dierent telomere
dynamis model providing requirements to study the eets of (a) dierent mean
telomere lengths in onstituting ells, as well as of (b) somati mutations leading
to aner progression and indenite proliferation due to telomerase ativity on the
ageing of organisms.
2 Basi model of biologial ageing due to telomere
attrition
Every organism is developed from a single progenitor ell, the zygote (gure 1).
The initial telomere length of zygote ells is assumed to be normally distributed with
mean µz and standard deviation σz [21℄. Telomere repeats lost per division (TRLPD)
are randomly hosen at eah division of every ell from a normal distribution with
mean µTRLPD and standard deviation σTRLPD. A dividing ell produes a lone who
inherits the repliative apaity of the progenitor ell at this age. Cells an divide
until nearly all their original telomeres are lost.
For every organism the dynamis of the model is as follows: Divisions of the
zygote and the stem ells derived from it our 6 times in the early embryo. Eah of
these ells is the progenitor of one tissue. This is followed by a period of population
doublings where all ells divide one in every timestep until 27 ells are present in
eah tissue. In the following maturation stage, ells are hosen randomly for division
until eah tissue reahes the adult size of 104 ells. It takes about 26 timesteps until
an organism is mature.
Ageing starts now. In every timestep rst ells die with 10% probability due to
events like nerosis or apoptosis. 10% of the ells of the orresponding tissue are
then randomly hosen for division to ll this gap. The replaement does not have to
be omplete as the hosen ell ould probably not divide anymore due to telomere
attrition. After some time the tissue will start shrinking. The random hoie of
dying and dividing ells in dierentiated tissues is in aordane with nature as
for example in epithelium the hoie of ells to be exported from the basal layer is
random [24, 25℄. The organism dies, if its total ell population size shrinks to 50% of
the mature size. The results presented in the following do not depend qualitatively
on the hoie of this threshold.
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Figure 1: Dynamis of ell proliferation in one organism in the basi model
3 Results without aner
In the implementation of this model, linear ongruential generators are used to
produe the required random numbers and normally distributed variables are gener-
ated with the Box-Muller algorithm [22, 23℄. Resulting age distributions for dierent
mean telomere lengths in the zygote ells are shown in (gure 2). The shape of these
distributions is analogous to empirial data of many human and animal populations.
We obtain a positive eet on the longevity of the organisms if the mean telomere
length in the preursor ell is inreased. The hosen mean doubling potentials of
the zygote ells are 30, 40 and 50 with the hoie of µz = 1500, 2000, 2500 and
µTRLPD = 50. The number of mitoti divisions observed in human broblasts is
higher [26℄, but the hoie of this parameter is reasonable as the number of on-
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Figure 2: Age distribution of 32000 organisms with telomere lengths of µz =
1500(+), µz = 2000(×) and µz = 2500(∗); σz = 100, µTRLPD = 50, σTRLPD = 10
sidered ells per mature organism (640000) in this model is also muh lower than
in human organisms where the total number of ells is of the order of 1013 [24℄.
Non-dividing ells are not inluded in the model as we fous on ageing due to the
progressive shrinking of tissues driven by telomere shortening. Our results will be
given below as part of Fig.5.
4 Introduing arinogenesis and telomerase
Clonal aner is now introdued in the model. In aordane to the model of Mool-
gavkar et al., one of our assumptions is that malignant tumors arise from indepen-
dently mutated progenitor ells [27℄. For most forms of arinoma, transformation
of a suseptible stem ell into a aner ell is suggested to be a multistage proess
of suessive mutations with a relatively low probability for the sequential stages
[8, 28℄. Two independent and irreversible hereditary mutation stages are onsidered
here, whih an our at every level of development of the organism during ell
division.
The rst premalignant stage to be onsidered is a promotion stage: A dividing
ell an mutate with small probability pmut [24℄. All desendant ells inherit this
mutation. This mutation leads to a partial esape from homeostati ontrol of
growth by the loal ellular environment [11, 29℄. Cells on the promotion stage have
a seletive advantage over unaeted ells [30℄. In our model they are hosen rst
for division during maturation and for lling up the gap in the ageing period.
The subsequent transition an our again with probability pmut during division.
If a ell reahes this seond stage of mutation it is a progenitor of a arinoma. An
explosive lonal expansion to a fully malignant ompartment happens [29℄. This ell
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and the lonal progeny doubles in the urrent timestep until it is no more possible
due to telomere attrition. This expansion leads only to an inrease of the malignant
ell population size. As a ertain fration of ells is killed per unit time and lonal
expansions only our with a very small probability, the tumor environments may
not ontinue growing, eventually shrink, or even die [31℄. We assume that it is
neessary for advaned aner progression and therefore for the development of a
deadly tumor that fully mutated ells are able to ativate telomerase [32℄.
In our model, telomerase ativation is possible at every age of the organism in
normal and mutated ells during division with a very low probability ptelo. The
irreversible loss of repliative potential is stopped in these ells. As the ontribution
of telomerase to tumorigeniity is not yet ompletely understood [33, 34, 35℄, we
assume that death of an organism due to aner ours if telomerase is reatived in
at least one fully mutated ell [36℄. We treat the time interval between the ourene
of the deadly tumor and death as onstant, so we set this interval to zero.
5 Eets of dierent telomere lengths onsidering
aner
Figure 3 shows simulation results for µz = 1500 and µz = 2500. As we onsider a
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Figure 3: Age distribution of 32000 organisms with telomere lengths of µz = 1500
with (∗) and without aner (+) and µz = 2500 with (✷) and without aner
(×); σz = 100, µTRLPD = 50, σTRLPD = 10. Caner mutations are possible with
pmut = 5 ∗ 10
−5
. Telomerase an be ativated with ptelo = 10
−5
.
lower omplexity by hosing a lower number of tissues and ells per organism, we
assume higher mutation rates for the inidene of aner than observed in nature
[37, 38℄. The age distribution for shorter initial telomere lengths onsidering aner
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is shifted to the left but still very old organisms exist. For longer telomeres the age
distribution is again shifted to the left but even behind the distributions for shorter
telomeres with and without onsidering arinogenesis.
0
20
40
60
80
100
120
140
160
180
200
1000 1200 1400 1600 1800 2000 2200 2400 2600
M
ea
n 
ag
e 
of
 d
ea
th
Mean zygote telomere length
Figure 4: Mean age of death for dierent inital zygote telomere lengths µz (32000
organisms) without aner (×) and introduing arinogenesis (+).
Thus without onsidering aner, organisms with longer zygote telomeres live
longer, as the life expetany of the organisms inreases linear for longer telomeres.
But if aner is onsidered this eet is reversed for longer initial mean telomere
lengths (g. 4).
The fore of mortality [39℄ resulting from this model is shown for µz = 1500 with
and without onsidering aner in omparison to empirial human mortality data
(gure 5). It agrees to some extent with human mortality funtions provided aner
is inorporated into the model and deelerates at advaned ages, as laimed for
human and animal populations [40, 41℄. The hump in the urve at younger ages,
ourring also for other parameter sets, ts to data of many human mortality tables.
6 Conlusion
The expeted simulation result of the basi model without aner is an inrease of
life span of most organisms with longer initial telomeres. After introduing somati
mutations promoting aner and telomerase ativation in this model, the survival
probability is lower for eah onsidered initial telomere length in ertain time inter-
vals in adult ages.
But even low probabilities for the two mutation stages and for the ativation of
telomerase lead to a strong redution of life span for longer telomeres. So the impli-
ation of two-stage arinogenesis for the inidene of aner in this simple model
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Figure 5: Mortality funtion for µz = 1500 with (×) and without aner (+), 32000
organisms onsidered, σz = 100, µTRLPD = 50, σTRLPD = 10; German men (∗) from
www.destatis.de (June 2004) (Sterbetafel 2000/2002)
of ell proliferation in organisms is that life expetany and life span of omplex
organisms annot be inreased by artiially elongating telomeres in primary ells,
for example during a loning proedure.
Further improvements, extentions and appliations of this model are possible.
With respet to the role of telomeres and telomerase in arinogenesis, maybe this
omputational approah an ontribute to the development of a omprehensive the-
oretial model in onology uniting mutagenesis and ell proliferation [42℄.
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